Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Mon, 18 Oct 02:14 PM

DIVIS LABORATORIES share price has hit an all-time high at Rs 5,425 (down 0.6%).

Meanwhile, the BSE HEALTHCARE Index is at 26,586 (down 0.5%).

Among the top gainers in the BSE HEALTHCARE Index today are DIVIS LABORATORIES (down 0.3%) and ABBOTT INDIA (up 0.3%).

PIRAMAL ENTERPRISES (down 0.1%) and NATCO PHARMA (down 0.1%) are among the top losers today.

Over the last one year, DIVIS LABORATORIES has moved up from Rs 3,145 to Rs 5,425, registering a gain of Rs 2,280 (up 69.9%).

The BSE HEALTHCARE has moved up from 20,145 to 26,586, registering a gain of 6,441 points (up 30.6%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were PIRAMAL ENTERPRISES (up 121.6%), LAURUS LABS (up 101.4%) and FORTIS HEALTHCARE (up 96.0%).

FREE REPLAY: Discover What Richa Revealed in Her Smallcaps Summit

What About the Benchmark Indices?

The BSE Sensex is at 61,962 (up 1.0%). The top gainers among the BSE Sensex stocks today are INFOSYS (up 3.7%), TATA STEEL (up 3.1%) and TECH MAHINDRA (up 2.7%). Other gainers include ICICI BANK (up 2.7%) and MARUTI SUZUKI (up 2.3%). The most traded stocks in the BSE Sensex are ITC and ONGC.

In the meantime, NSE Nifty is at 18,543 (up 1.0%). The top gainers in the NSE Nifty include HINDALCO (up 4.9%), JSW STEEL (up 4.2%) and INFOSYS (up 3.9%). Other gainers include TATA MOTORS (up 3.1%) and TECH MAHINDRA (up 3.0%).

Over the last 12 months, the BSE Sensex has moved up from 40,626 to 61,962, registering a gain of 21,336 points (up 52.4%).

DIVIS LABORATORIES Financial Update...

DIVIS LABORATORIES net profit stood at Rs 6 billion for the quarter ended June 2021, compared to a profit of Rs 5 billion a year ago. Net Sales rose 15.2% to Rs 19.6 billion during the period as against Rs 17.0 billion in April-June 2020.

For the year ended March 2021, DIVIS LABORATORIES reported 44.2% increase in net profit to Rs 19.8 billion compared to net profit of Rs 13.8 billion during FY20.

Revenue of the company grew 29.2% to Rs 70 billion during FY21.

The current Price to earnings ratio of DIVIS LABORATORIES, based on rolling 12 month earnings, stands at 69.2x.

What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "DIVIS LABORATORIES at All Time High; BSE HEALTHCARE Index Down 0.5%". Click here!


Stock Market Updates

Sensex Recoups Early Losses as Energy, Metal Stocks Rally; Reliance & Tata Steel Top Gainers (Today's Market)

Nov 29, 2021 10:30 am

Asian share markets are trading lower today as the spread of the Omicron variant in developed nations threatened to derail economic recoveries and the tightening plans of some central banks.

SGX Nifty Up 148 Points; Indicates Gap-Up Opening for Indian Stock Markets (Today's Market)

Nov 29, 2021 SGX Nifty

Trends on SGX Nifty indicate a gap-up opening for Indian stock markets.

5 Reasons Why Sensex Crashed, Tarsons Products' Lukewarm Debut, and Buzzing Stocks Today (Today's Market)

Nov 29, 2021 Pre-Open

Top cues to track in today's stock market session.

View More Indian Share Market News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

How to Find Your Next 10-Bagger in this Market(Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.


Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Nov 29, 2021 03:15 PM